Rockefeller Capital Management’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
KGAMU
WPM
RC
QOP
Rockefeller Capital Management's CDLX Position: Q2 2026 in Review
Rockefeller Capital Management sold out of Cardlytics (CDLX) in Q2 2026, closing a stake of 225 shares — an estimated $2.36K sold.
Rockefeller Capital Management first reported a position in CDLX in Q3 2018 and held it in 16 quarters. The position peaked at $27M in Q4 2020. 42 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.
- Rockefeller Capital Management reported no remaining Cardlytics position as of Q2 2026 after selling out during the quarter.
- Rockefeller Capital Management sold 225 Cardlytics shares in Q2 2026, an estimated $2.36K.
- Rockefeller Capital Management first reported a position in Cardlytics in Q3 2018 and held it in 16 quarters.
- Rockefeller Capital Management's Cardlytics position peaked at $27M in Q4 2020.
- 42 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.
Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.